Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predictive Value of FDG-TEP During Radiotherapy (RT) or Chemo-radiotherapy (CRT) in Patients With Non Small Cell Lung Cancer on the One-year Survival

NCT01261598 is registered in ClinicalTrials.gov with Centre Henri Becquerel as lead sponsor.

NCT NCT01261598
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01261598 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predictive Value of FDG-TEP During Radiotherapy (RT) or Chemo-radiotherapy (CRT) in Patients With Non Small Cell Lung Cancer on the One-year Survival
Lead sponsor
Centre Henri Becquerel
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2007
Completion date
December 31, 2013
Enrollment
98 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer, nsclc